In summary, this report is the first to show that ZNF545 is a functional TSG in breast cancer, through inhibiting cell growth and inducing apoptosis, and its tumor-specific methylation may serve as a potential tumor marker for breast cancer. This evidence concerns the gene ZFP82 and breast cancer.